Rahul D. Ballal

Companies

• Agios PharmaceuticalsBoard member Aug 15, 2022 to now¹
• Enliven Therapeutics, Inc.Board member Mar 11, 2020 to now²
• Enliven Therapeutics, Inc.Chief executive officer Mar 11, 2020 to Feb 22, 2023²
• Enliven Therapeutics, Inc.President Mar 11, 2020 to Mar 11, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEnliven Therapeutics, Inc. ELVN22,341 shares³$856.3K at $38.33Oct 8, 2024
• Agios Pharmaceuticals AGIO15,230 shares⁴$523.3K at $34.36Jun 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 18, 2026Exercised options 2,816 shares of Agios Pharmaceuticals⁴
• Aug 11, 2025Exercised options 2,302 shares of Agios Pharmaceuticals⁵
• Jun 20, 2025Exercised options 2,120 shares of Agios Pharmaceuticals⁶
• Nov 8, 2024Sold 1,500 shares at $59.21 of Agios Pharmaceuticals⁷
• Nov 8, 2024Sold 4,929 shares at $58.57 of Agios Pharmaceuticals⁷
• Nov 8, 2024Sold 3,571 shares at $57.24 of Agios Pharmaceuticals⁷
• Nov 8, 2024Exercised options 10,000 shares at $25.99 of Agios Pharmaceuticals⁷
• Nov 7, 2024Sold 1,868 shares at $54.41 of Agios Pharmaceuticals⁷
• Nov 7, 2024Sold 8,132 shares at $53.32 of Agios Pharmaceuticals⁷
• Nov 7, 2024Exercised options 10,000 shares at $25.99 of Agios Pharmaceuticals⁷
• Oct 8, 2024Sold 10,420 shares at $28.17 of Enliven Therapeutics, Inc.³
• Oct 8, 2024Exercised options 4,106 shares at $5.52 of Enliven Therapeutics, Inc.³
• Oct 8, 2024Exercised options 6,314 shares at $19.68 of Enliven Therapeutics, Inc.³
• Aug 11, 2024Exercised options 2,302 shares of Agios Pharmaceuticals⁸
• Jun 13, 2024Exercised options 3,388 shares of Agios Pharmaceuticals⁹
• Apr 11, 2024Sold 3,068 shares at $25.21 of Enliven Therapeutics, Inc.¹⁰
• Apr 11, 2024Sold 20,032 shares at $25.00 of Enliven Therapeutics, Inc.¹⁰
• Apr 11, 2024Sold 30,300 shares at $23.14 of Enliven Therapeutics, Inc.¹⁰
• Apr 11, 2024Exercised options 4,580 shares at $19.68 of Enliven Therapeutics, Inc.¹⁰
• Apr 11, 2024Exercised options 48,820 shares at $12.60 of Enliven Therapeutics, Inc.¹⁰
• Apr 10, 2024Sold 13,600 shares at $21.01 of Enliven Therapeutics, Inc.¹⁰
• Apr 10, 2024Exercised options 13,600 shares at $12.60 of Enliven Therapeutics, Inc.¹⁰
• Apr 4, 2024Sold 3,485 shares at $19.15 of Enliven Therapeutics, Inc.¹¹
• Apr 4, 2024Exercised options 3,485 shares at $12.60 of Enliven Therapeutics, Inc.¹¹
• Apr 1, 2024Sold 3,237 shares at $19.08 of Enliven Therapeutics, Inc.¹²